Yahoo Web Search

Search results

1. • Boehringer Ingelheim's COPD and asthma inhalers are now available for $35 a month for eligible...

     The Sun Chronicle· 2 days ago

     Boehringer Ingelheim's new program to cap out-of-pocket costs at $35 per month for eligible patientsi for the company's inhalers is now available. With this program, patients who have had difficulty ...

2. • Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald

     Roanoke-Chowan News-Herald· 4 days ago

     The FDA did not raise any concerns regarding the approvability of Dupixent for this indication. The FDA had requested additional analyses on the efficacy of Dupixent in the ...

3. • 

     FDA delays decision on Dupixent in COPD; Summit makes a bold claim

     BioPharma Dive via Yahoo Finance· 3 days ago

     Regeneron and Sanofi now expect an FDA verdict in September. Elsewhere, Summit claimed victory over...

4. • 

     FDA Extends Review Deadline For Regeneron/Sanofi's Dupixent For 'Smoker's Lungs' Disease

     Benzinga via Yahoo Finance· 3 days ago

     On Friday, the FDA extended the target action date of priority review of supplemental application...

5. • Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald

     Roanoke-Chowan News-Herald· 4 days ago

     The European Commission is expected to announce a final decision on the Dupixent application in the coming months.

6. • 

     The Next Humira? Insmed Catapults 119% On Its 'Very Attractive' Opportunity In Lung Disease.

     Investor's Business Daily· 6 days ago

     Dupixent, a treatment for asthma, eczema and other diseases, brought $11.6 billion in sales last...

7. • 

     Council Post: The Rise Of Large Language Models: A Helping Hand For Healthcare?

     Forbes· 6 days ago

     Although these tasks are essential for making informed decisions around screening, treatment and...

8. • 

     Lung Scarring: What to Know

     Verywell Health via Yahoo News· 4 days ago

     For most people, the ability to breathe becomes more difficult over time. Still, medications and treatment can help. The most serious complication from...

9. • 

     FDA Extends Review Deadline For Regeneron/Sanofi's Dupixent For 'Smoker's Lungs' Disease

     Benzinga· 3 days ago

     On Friday, the FDA extended the target action date of priority review of supplemental application...

10. • 

      Whooping cough cases on the rise nationwide

      CBS News· 3 days ago

      Rising whooping cough cases are raising health concerns nationwide, including in Pennsylvania. No parent wants their child to suffer from pertussis, also...